Clindamycin, Cephalosporins, Fluoroquinolones, andClostridium difficile–Associated Diarrhea: This Is an Antimicrobial Resistance Problem
Open Access
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (5), 646-648
- https://doi.org/10.1086/382084
Abstract
Clostridium difficile–associated diarrhea (CDAD) is a unique hospital infection that occurs almost entirely in patients who have received previous antimicrobialKeywords
This publication has 10 references indexed in Scilit:
- Outbreak ofClostridium difficileInfection in a Long‐Term Care Facility: Association with Gatifloxacin UseClinical Infectious Diseases, 2004
- Fluoroquinolone Use andClostridium difficile–associated DiarrheaEmerging Infectious Diseases, 2003
- Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated DiarrheaInfection Control & Hospital Epidemiology, 2001
- Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective studyJournal of Antimicrobial Chemotherapy, 2001
- In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolatesJournal of Antimicrobial Chemotherapy, 2000
- Epidemics of Diarrhea Caused by a Clindamycin-Resistant Strain ofClostridium difficilein Four HospitalsNew England Journal of Medicine, 1999
- Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin–tazobactamAlimentary Pharmacology & Therapeutics, 1998
- Risk factors for Clostridium difficile infectionJournal of Hospital Infection, 1998
- Enterobacter Plasmids: Molecular Epidemiology (with Reply)Infection Control & Hospital Epidemiology, 1995
- Ciprofloxacin and Clostridium difficile-associated diarrhoeaJournal of Antimicrobial Chemotherapy, 1992